Ch 39 Flashcards
HTN
Increase in blood pressure (BP) → systolic blood pressure (SBP) > 90 mm Hg and diastolic blood pressure (DBP) > 90 mm Hg
essential HTN (what is it, origin, contributing factors)
Most common: affecting 90% of persons with high blood pressure.
ii. Exact origin is unknown
iii. Contributing factors include
1. Stress
2. Aging
3. Diabetes
4. Obesity
5. Smoking
6. Family history
7. Hyperlipidemia
8. Excessive alcohol
9. African-American background
secondary HTN
10% of hypertension cases are related to renal and endocrine disorders and classified as secondary hypertension
BP regulators
KIDNEYS (work with blood vessels to regulate/maintain normal BP.)
-Regulate by control of fluid and volume, and RAAS system
-control sodium and water elimination/retention > affecting cardiac output, and arterial blood pressure
BARORECEPTORS: In aorta, carotid sinus, and vasomotor center in the medulla aid in regulation of blood pressure. Catecholamine (norepinephrine and epinephrine) increase blood pressure through vasoconstriction activity.
HORMONES
1. ADH- antidiuretic hormone
2. ANP- atrial natriuretic peptide
3. BNP- brain natriuretic peptide
physiologic risk factors for HTN
i. Obesity → affects cardiovascular and sympathetic systems
ii. Alcohol consumption increases renin secretion
iii. Diet high in saturated fat and simple carbohydrates
cultural responses to antihypertensive agents
- African Americans are more likely to develop hypertension at an earlier age. Also have higher mortality rate from hypertension. Susceptible to low-renin hypertension, therefore use of beta blockers and ACE-I are less effective in controlling blood pressure, unless combined with a diuretic. Better response to alpha 1 blockers, calcium channel blockers, diuretics
- Asian Americans are 2x more sensitive to antihypertensive medication than Caucasians
- Native Americans have a reduced or lower response to beta blockers compared to Caucasians
- Caucasians usually have high-renin hypertension and respond well to all antihypertensive agents.
HTN with adults
i. 70 million American adults (1 in 3) have hypertension
ii. 65% of individuals > 60 yo have developed hypertension
HTN with older adults
iii. Oder adults affected by orthostatic (postural) hypotension with use of antihypertensive medications
1. Sudden drop in BP when going from lying or sitting to upright position, causing dizziness d/t blood pooling in lower extremities
nonpharma control of HTN
a. Nonpharmacologic measures should be instituted first, to attempt to decrease blood pressure. These include stress-reduction techniques, exercise, salt restriction, ↓ alcohol intake, smoking cessation
b. Antihypertensive medications are usually initiated with consistent systolic readings of >140
JNC BP guidelines
purpose: reduce risk of CVD.
pre: SBP 120-139, DBP 80-89
stage 1: 140/90-159/99
stage 2: 160/100 or up
is SBP or DBP more important for CVD risk in HTN?
sbp
pharma control of HTN
- diuretics
- sympatholytics
- direct acting arteriolar vasodilators
- ACE-I (pril)
- ARBs
- calcium channel blockers (calcium blockers)
how do diuretics control bP
Promote sodium depletion > decreases extracellular fluid volume. Effective for first line drugs for mild hypertension
sympatholytics for BP?
five groups of medications: (1) Beta-adrenergic blockers (2) alpha2 agonists (3) alpha adrenergic blockers (4) adrenergic neuron blockers (5) alpha 1 and beta1 adrenergic blockers. (lecture focus on 1, 2 and 3)
beta adrenergic blockers
sympatholytics.
(beta blockers).
Used as antihypertensive drugs, or in combination with diuretics. Can also be used as antianginals and antidysrhythmics. Reduce cardiac output by diminishing sympathetic nervous system response to decreased basal sympathetic tone. Reduce heart rate, contractility, and release of renin. Nonselective and selective
i. Nonselective - affect beta 1(heart) & beta 2 (bronchial) receptors: Heart rate slows, BP ↓, bronchoconstriction occurs
ii. Selective – preferred because they affect mainly beta1 heart receptors, so bronchoconstriction is less likely to occur
metoprolol (lopressor) PD/PT/CI/PREC
pd: blocks beta1 receptors (cardioselective).
PT: HTN, HF, acute MI, angina.
CI: heart block, cardiogenic shock, hypotn, acute HF, sinus brady.
prec: hep/renal, thyroid dysfx, asthma, PVD, DM, depression
metoprolol adv/se/dfl/ni/pt ed
adv: Bradycardia, thrombocytopenia, stroke, diabetes mellitus
-Life threat: AV heart block, bronchospasm, agranulocytosis, HF
SE: Fatigue, weakness, dizziness, dry mouth, n/v/d, short-term memory loss, drowsiness, headache, blurred vision, photosensitivity, nasal congestion, peripheral edema, tinnitus, erectile dysfunction, depression
Drug: Increased bradycardia with digitalis, clonidine, SSRIs, MAOIs, cimetidine. Increased hypotensive effect with other antihypertensives, alcohol, anesthetics.
NSAIDs decrease effect of beta blockers
Lab:Increased hepatic enzymes
NI: Obtain medication/herbal hx for possible interactions, base VS. Baseline liver and renal labs and cardiac enzymes. Monitor vital signs, especially BP and pulse, Monitor lab values: BUN, CRT, AST, LDH
PT ED: Check blood pressure and pulse (heart rate) before taking. Report any adverse effects to your healthcare provider immediately. If diabetic educate potential for hypoglycemia. Rise slowly from sitting to standing due to risk of orthostatic hypotension. Wear a medic-alert bracelet. Avoid taking herbs and OTC medications without first discussing with healthcare provider. Teach nonpharmacologic methods to decrease BP
centrally acting alpha 2 agents
Decrease sympathetic response from the brainstem into peripheral vessels
b. Stimulate Alpha2 receptors > decreases sympathetic activity > increased vagus activity > decreases cardiac output > all result in reduce peripheral vascular resistance, and increased vasodilation
c. Minimal effect on cardiac output, and blood flow to the kidneys
clonidine (catapres)
centrally acting alpha 2 agonist.
i. Can cause sodium and water retention in high doses > peripheral edema
ii. Frequently administered with diuretics
iii. Available as a transdermal patch worn for 7 days at a time
iv. Cannot abruptly discontinue > risk for rebound hypertension
alpha adrenergic blockers
a. Block alpha-adrenergic receptors> vasodilation, and decreased blood pressure
b. Help maintain renal blood flow rate
c. Useful in treating hypertension in patients with lipid abnormalities can decrease VLDL, and LDL responsible for buildup of fatty plaques in the arteries, and increase HDL
d. Safe for patients with diabetes; they do not affect glucose metabolism
e. Do not affect respiratory funcion
f. Given to patients with BPH (benign prostatic hypertrophy)
prazosin (minipress) PD, PT, CI, PREC
PD: Dilates peripheral blood vessels by blocking alpha-adrenergic receptors
PT: HTN, refractory HF, bPH
CI: Renal disease
PREC: Angina, orthostatic HT, syncope, pregnancy, breastfeeding
prazosin (minipress) ADV, SE, DFL, NI, PT ED
ADV: Orthostatic hypotension, palpitations, tachycardia, pancreatitis, elevated liver enzymes
SE: Dizziness, drowsiness, nervousness, blurred vision, tinnitus, fatigue, headache, depression, nasal congestion, dry mouth, n/v/d/c, abdominal pain, impotence, urinary incontinence, peripheral edema, erectile dysfunction
DRUG: Increased hypotensive effect with other antihypertensives, nitrates, alcohol. Decreased effects with NSAIDs
LAB: Increased hepatic enzymes
NI: Baseline VS, Medication history. Report probable drug/herbal interactions. Check urinary o/p →drug contraindicated if renal dx present. report sudden decrease in BP and tachycardia. Check for peripheral edema and ↑weight. Prazosin may cause sodium and water retention
PT ED: Check blood pressure and pulse (heart rate) before taking. in high doses > impotence can occur in males > contact healthcare provider. Report any adverse effects to your healthcare provider immediately. Rise slowly from sitting to standing due to risk of orthostatic hypotension. Must take exactly as prescribed > do not abruptly stop > risk of rebound hypertension. Avoid taking OTC medications without first discussing with healthcare provider. Wear a medic-alert bracelet. May cause peripheral edema > monitor weight due to risk of fluid retention
direct acting arteriolar vasodilators
i. Act by relaxing smooth muscles of the blood vessels, mainly arteries
ii. Promote increased blood flow to brain and kidneys
iii. Vasodilation> decrease in blood pressure, however, sodium and water are retained > peripheral edema > may need to give with diuretic
hydralazine (apresoline) PD, PT, CI, PREC
direct acting arteriolar vasodilator.
PD: Relaxes smooth muscles > vasodilation
PT: Hypertension, hypertensive emergency, preeclampsia, eclampsia. May be used in conjunction with diuretic or beta blocker
CI: Pregnancy category C
PREC: tachycardia